Cover Image
市場調查報告書

轉移性移形上皮(尿道上皮)癌症:全球臨床實驗檢討

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 299729
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
轉移性移形上皮(尿道上皮)癌症:全球臨床實驗檢討 Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月15日 內容資訊: 英文 107 Pages
簡介

本報告提供轉移性移形上皮(尿道上皮)癌症相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、各階段、Phase別的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • 轉移性移形上皮(尿道上皮)癌症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

在G7各國臨床實驗數量:佔腫瘤整體比率

在G7各國臨床實驗數量:各階段(Phase別)

在G7各國臨床實驗數量:各進展狀況

在E7各國臨床實驗數量:佔腫瘤整體比率

在E7各國臨床實驗數量:各階段(Phase別)

在E7各國臨床實驗數量:各進展狀況

各階段(Phase別)臨床實驗數量

  • 進行中的臨床實驗:Phase別

各進展狀況臨床實驗數量

臨床實驗的目標的成就情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商的不同種類的臨床實驗數量

有潛力的贊助商

  • 參加轉移性移形上皮(尿道上皮)癌症治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Zeltia, S.A.
    • Wissenschaftlicher Service Pharma GmbH
    • Sanofi
    • Lukaskrankenhaus GmbH
    • F. Hoffmann-La Roche Ltd.
    • Astellas Pharma Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • Karolinska University Hospital
    • 北里大學醫學系
    • Campania Younger Oncologists Association
    • 久留米大學
    • China Medical University Hospital
    • Centre Val d'Aurelle - Paul Lamarque
    • The University of Chicago
    • University of Kentucky

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2076CTIDB

GlobalData's clinical trial report, "Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Transitional (Urothelial) Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Transitional (Urothelial) Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Transitional (Urothelial) Tract Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Metastatic Transitional (Urothelial) Tract Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Metastatic Transitional (Urothelial) Tract Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials
  • Prominent Drugs
    • Clinical Trial Profiles
      • Clinical Trial Overview of Top Companies
      • Zeltia, S.A.
      • Clinical Trial Overview of Zeltia, S.A.
      • Wissenschaftlicher Service Pharma GmbH
      • Clinical Trial Overview of Wissenschaftlicher Service Pharma GmbH
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Lukaskrankenhaus GmbH
      • Clinical Trial Overview of Lukaskrankenhaus GmbH
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Karolinska University Hospital
      • Clinical Trial Overview of Karolinska University Hospital
      • Kitasato University School of Medicine
      • Clinical Trial Overview of Kitasato University School of Medicine
      • Campania Younger Oncologists Association
      • Clinical Trial Overview of Campania Younger Oncologists Association
      • Kurume University
      • Clinical Trial Overview of Kurume University
      • China Medical University Hospital
      • Clinical Trial Overview of China Medical University Hospital
      • Centre Val d'Aurelle - Paul Lamarque
      • Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque
      • The University of Chicago
      • Clinical Trial Overview of The University of Chicago
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeltia, S.A., 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wissenschaftlicher Service Pharma GmbH, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lukaskrankenhaus GmbH, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska University Hospital, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kitasato University School of Medicine, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Campania Younger Oncologists Association, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014*

List of Figures

  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top